One of the pharmaceutical industry’s biggest cautionary tales has a better storyline these days. Bausch Health Cos Inc. — the business formerly known as Valeant Pharmaceuticals — reported earnings results
(Reuters) - The U.S. Food and Drug Administration on Thursday approved Bausch Health Companies Inc’s topical plaque psoriasis treatment, which is expected to be a key revenue driver for the company. Duobrii,
The company formerly known as Valeant is buying Synergy, the company behind those poop emojis Bausch Health, formerly known as Valeant Pharmaceuticals, is back in the acquisitions game after a long hiatus.
Bausch Health Companies Inc. reported a loss of $350 million in its latest quarter as its revenue moved lower. The company formerly known as Valeant Pharmaceuticals says the loss for the quarter ended